Bristol-Myers Squibb (BMY) – Analyst Comments
-
Deutsche Bank on Bristol-Myers Squibb Co. (BMY): FDA Approval of KarMMA-3 Meets Commercial Reality Check
-
Societe Generale Downgrades Bristol-Myers Squibb Co. (BMY) to Hold, 'ranks at the bottom of SG’s global peer group'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BMY Stock Lookup